Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA BiosciencesPRNewsWire • Wednesday
Kintara Therapeutics Provides Update on Corporate Developments and REM-001 Clinical StudyPRNewsWire • 09/11/24
Kintara Therapeutics to Hold Special Meeting of Stockholders to Allow for Completion of the Proposed Merger with TuHURA Biosciences, Inc.PRNewsWire • 09/09/24
TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor CancerPRNewsWire • 08/19/24
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint InhibitorPRNewsWire • 07/08/24
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term MilestonesPRNewsWire • 07/01/24
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)PRNewsWire • 06/03/24
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRAPRNewsWire • 04/10/24
KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRABusiness Wire • 04/05/24
Shareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURAPRNewsWire • 04/03/24
KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 04/03/24
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger AgreementPRNewsWire • 04/03/24
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on PembrolizumabPRNewsWire • 03/27/24
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/24
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast CancerPRNewsWire • 02/12/24
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA)Benzinga • 01/02/24
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)Benzinga • 12/18/23
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing RequirementPRNewsWire • 12/05/23
Top 5 Health Care Stocks That Could Blast Off In December - DBV Technologies (NASDAQ:DBVT), Cigna Group (NYSE:CI)Benzinga • 12/01/23
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/13/23